Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeselskabet Ringe Tandlægehus ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   2.1% 1.9% 1.8% 1.7% 2.1% 1.4% 8.2% 8.2%   Credit score (0-100)   69 71 71 72 67 77 30 30   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   0.8 2.2 3.9 9.6 0.6 55.7 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -47.5 -127 58.4 472 -154 -152 0.0 0.0   EBITDA   -322 -297 -60.2 186 -344 -324 0.0 0.0   EBIT   -387 -362 -131 128 -388 -368 0.0 0.0   Pre-tax profit (PTP)   -343.4 50.7 78.7 -202.1 -2,550.4 306.4 0.0 0.0   Net earnings   -270.1 37.7 61.0 -371.0 -2,265.0 240.8 0.0 0.0   Pre-tax profit without non-rec. items   -343 50.7 78.7 -202 -2,550 306 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   4,047 4,141 4,436 186 142 98.6 0.0 0.0   Shareholders equity total   9,761 9,691 9,641 9,157 6,778 6,901 6,679 6,679   Interest-bearing liabilities   1,269 1,098 897 8.9 14.1 18.4 0.0 0.0   Balance sheet total (assets)   11,686 11,145 10,862 9,497 6,861 6,963 6,679 6,679   Net Debt   -1,198 -777 -251 -6,088 -4,527 -4,942 -6,679 -6,679     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -47.5 -127 58.4 472 -154 -152 0.0 0.0   Gross profit growth   0.0% -166.3% 0.0% 707.8% 0.0% 1.3% 0.0% 0.0%   Employees   0 1 1 1 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 100.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   11,686 11,145 10,862 9,497 6,861 6,963 6,679 6,679   Balance sheet change%   0.0% -4.6% -2.5% -12.6% -27.8% 1.5% -4.1% 0.0%   Added value   -322.5 -296.6 -60.2 185.5 -330.5 -324.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   3,982 29 224 -4,307 -88 -88 -99 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 -3.0 1.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   813.1% 286.2% -224.6% 27.1% 251.7% 241.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -1.5% 0.6% 1.1% 8.5% 8.7% 4.5% 0.0% 0.0%   ROI %   -1.5% 0.6% 1.1% 8.6% 8.9% 4.5% 0.0% 0.0%   ROE %   -2.8% 0.4% 0.6% -3.9% -28.4% 3.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   83.5% 87.0% 88.8% 96.4% 98.8% 99.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   371.4% 261.8% 417.4% -3,281.1% 1,314.4% 1,523.1% 0.0% 0.0%   Gearing %   13.0% 11.3% 9.3% 0.1% 0.2% 0.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   27.0% 1.6% 4.3% 234.5% 28,397.4% 13.5% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   3.5 3.9 2.8 18.0 60.8 83.7 0.0 0.0   Current Ratio   3.5 3.9 2.8 18.0 60.8 83.7 0.0 0.0   Cash and cash equivalent   2,466.3 1,875.0 1,148.5 6,096.6 4,540.6 4,960.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -45.1 -389.5 -278.0 -202.7 502.2 390.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 -297 -60 186 -165 -162 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 -297 -60 186 -172 -162 0 0   EBIT / employee   0 -362 -131 128 -194 -184 0 0   Net earnings / employee   0 38 61 -371 -1,133 120 0 0